By Tiffany Hu ( January 19, 2021, 9:59 PM EST) -- The Patent Trial and Appeal Board has refused to review a Novartis Pharma AG patent covering a syringe meant for eye injections, citing the "advanced stage" of a parallel case involving the same parties before the U.S. International Trade Commission....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.